Advances in Pediatric Renal Replacement Therapy

Advances in Chronic Kidney Disease

Volumn 18, Issue 5, 2011, Pages 376-383

  Sebestyen, Judith F ^a   Warady, Bradley A ^a  

^a CHILDREN S MERCY HOSPITAL   (United States)

Author keywords

Dialysis; Hemodialysis; Peritoneal

Indexed keywords

ACUTE KIDNEY FAILURE; CHILD CARE; CHRONIC DISEASE; CLINICAL EFFECTIVENESS; CONTINUOUS RENAL REPLACEMENT THERAPY; HEMODIALYSIS; KIDNEY FAILURE; PATIENT SAFETY; PERITONITIS; PRIORITY JOURNAL; REVIEW; VASCULAR DISEASE;

ACUTE KIDNEY INJURY; ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; KIDNEY FAILURE, CHRONIC; MALE; RENAL REPLACEMENT THERAPY; YOUNG ADULT;

EID: 80052396444     PISSN: 15485595     EISSN: 15485609     Source Type: Journal    
DOI: 10.1053/j.ackd.2011.07.003     Document Type: Review

References (61)

1. United States Renal Data System (USRDS) 2009 Annual Data Report (ADR): chronic kidney disease in the adult NHANES population. Available at: http://www.usrds.org.
2. North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) 2011 Annual Report. Available at: http://www.naprtcs.org.
3. Mitsnefes M.M. Complications of pediatric chronic kidney disease. Pediatric Nephrol 2008, 23:27-39.
4. Wang A.Y., Wang M., Woo J., et al. Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients. J Am Soc Nephrol 2004, 15:2186-2194.
5. United States Renal Data System: 2007 Annual Report. Available at: http://www.usrds.org/2007/pdf_07.pdf.
6. Goodman W.G., Goldin J., Kuizon B.D., et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000, 342:1478-1482.
7. Furth S.L., Hwang W., Yang C., Neu A.M., Fivush B.A., Powe N.R. Relation between pediatric experience and treatment recommendations for children and adolescents with kidney failure. JAMA 2001, 28:1027-1033.
8. Goldstein S.L., Silverstein D.M., Leung J.C., et al. Frequent hemodialysis with NxStage system in pediatric patients receiving maintenance hemodialysis. Pediatr Nephrol 2008, 23:129-135.
9. Shroff R., Wright E., Ledermann S., Hutchinson C., Rees L. Chronic hemodialysis in infants and children under 2 years of age. Pediatr Nephrol 2003, 18:378-383.
10. Al-Hermi B.E., Al-Saran K., Secker D., Geary D.F. Hemodialysis for end-stage renal disease in children weighing less than 10 kg. Pediatr Nephrol 1999, 13:401-403.
11. Warady B.A., Alexander S.R., Watkins S., Kohaut E., Harmon W.E. Optimal care of the pediatric end-stage renal disease patient on dialysis. Am J Kidney Dis 1999, 33:567-583.
12. Sheth R., Brandt M., Brewer E., et al. Permanent hemodialysis vascular access survival in children and adolescent with end-stage renal disease. Kidney Int 2002, 62:1864-1869.
13. Peritoneal Dialysis Adequacy Work Group Clinical practice guidelines for peritoneal dialysis adequacy. Am J Kidney Dis 2006, 48:S98-S129.
14. Fadrowski J.J., Hwang W., Neu A.M., Fivush B.A., Furth S.L. Pattern of use of vascular catheter for hemodialysis in children in the united states. Am J Kidney Dis 2009, 53:91-98.
15. Brereketeab H., Vandevoorde R., George C., Warady B. Ash split catheter usage in children receiving chronic hemodialysis. Hemodialysis Int 2010, 14:139.
16. Sheth R.D., Kale A.S., Brewer E.D., Brandt M.L., Nuchtern J.G., Goldstein S.L. Successful use of Tesio catheters in pediatric patients receiving chronic hemodialysis. Am J Kidney Dis 2001, 38:553-559.
17. Zaritsky J.J., Salusky I.B., Gales B., et al. Vascular access complications in long-term pediatric hemodialysis patients. Pediatr Nephrol 2008, 23:2061-2065.
18. Eisenstein I., Tarabeih M., Magen D., et al. Low infection rates and prolonged survival times of hemodialysis catheters in infants and children. Clin J Am Soc Nephrol 2011, 6:793-798.
19. Onder A.M., Billings A., Chandar J., et al. PREFABL: predictors of failure of antibiotic locks for the treatment of catheter-related bacteraemia. Nephrol Dial Transplant 2010, 25:3686-3693.
20. Warady B.A., Jabs K., Goldstein S.L. Chronic dialysis in children. Principle and Practice of Dialysis 2009, 613-640. Lippincott Williams & Wilkins, Philadelphia, PA. W.L. Henrich (Ed.).
21. Goldstein S., Currier H., Watters L., et al. Acute and chronic inflammation in pediatric patients receiving hemodialysis. J Pediatr 2003, 143:653-657.
22. Gorman G., Furth S., Hwang W., et al. Clinical outcomes and dialysis adequacy in adolescent hemodialysis patients. Am J Kidney Dis 2006, 47:285-293.
23. Goldstein S.L. Hemodialysis in the pediatric patient: state of the art. Adv Ren Replace Ther 2001, 8:173-179.
24. Grupe W., Harmon W., Spinozzi N. Protein and energy requirements in children receiving chronic hemodialysis. Kidney Int 1983, 15:S6-S10.
25. Orellana P., Juarez-Congelosi M., Goldstein S.L. Intradialytic parenteral nutrition treatment and biochemical marker assessment for malnutrition in adolescent maintenance hemodialysis patients. J Ren Nutr 2005, 15:312-317.
26. Michael M., Brewer E.D., Goldstein S.L. Blood volume monitoring to achieve target weight in pediatric hemodialysis patients. Pediatr Nephrol 2004, 19:432-437.
27. Jain S.R., Smith L., Brewer E.D., Goldstein S.L. Non-invasive intravascular monitoring in the pediatric hemodialysis population. Pediatr Nephrol 2001, 16:15-18.
28. Geary D.F., Piva E., Tyrrell J., et al. Home nocturnal hemodialysis in children. J Pediatr 2005, 147:383-387.
29. Fischbach M., Terzic J., Menouer S., et al. Intensified and daily hemodialysis in children might improve statural growth. Pediatr Nephrol 2006, 21:1746-1752.
30. Warady B.A., Fischbach M., Geary D., Goldstein S.L. Frequent hemodialysis in children. Adv Chronic Kidney Dis 2007, 14:297-303.
31. Mammen C., Goldstein S.L., Milner R., White C.T. Standard Kt/V thresholds to accurately predict single-pool Kt/V targets for children receiving thrice-weekly maintenance haemodialysis. Nephrol Dial Transplant 2010, 25:3044-3050.
32. Warady B.A., Schaefer F., Alexander S.R., Firanek C., Mujais S. Care of the pediatric patient on peritoneal dialysis: clinical process for optimal outcomes 2004, Baxter Healthcare, Deerfield, IL, pg. 12.
33. Lane J.C., Warady B.A., Feneberg R., et al. Relapsing peritonitis in children who undergo chronic peritoneal dialysis: a prospective study of the International Pediatric Peritonitis Registry. Clin J Am Soc Nephrol 2010, 5:1041-1046.
34. Auron A., Simon S., Andrews W., et al. Prevention of peritonitis in children receiving peritoneal dialysis. Pediatr Nephrol 2007, 22:578-585.
35. Chadha V., Jones L.L., Ramirez Z.D., Warady B.A. Chest wall peritoneal dialysis catheter placement in infants with a colostomy. Adv Perit Dial 2000, 16:318-320.
36. Warady B.A., Alexander S.R., Hossli S., et al. Peritoneal membrane transport function in children receiving long-term dialysis. J Am Soc Nephrol 1996, 7:2385-2391.
37. Warady B.A., Jennings J. The short PET in pediatrics. Perit Dial Int 2007, 27:441-445.
38. Fischbach M., Warady B. Peritoneal dialysis prescription in children: bedside principles for optimal practice. Pediatr Nephrol 2009, 24:1633-1642.
39. Dart A., Feber J., Wong H., Filler G. Icodextrin re-absorption varies with age in children on automated peritoneal dialysis. Pediatr Nephrol 2005, 20:683-685.
40. Bakkaloglu SA, Borzych D, Ha IS, et al. International Pediatric Network. Cardiac geometry in children receiving chronic peritoneal dialysis: findings from the International Pediatric Network (IPPN) Registry. Clin J Am Soc Nephrol. In press.
41. Borzych D, Bakkaloglu SA, Zaritsky J, et al. International Pediatric Network. Defining left ventricular hypertrophy in children on peritoneal dialysis. Clin J Am Soc Nephrol. In press.
42. Morgenstern B., Wuhl E., Sreekumaran Nair K., Warady B., Schaefer F. Anthropometric prediction of total body water in children who are on pediatric peritoneal dialysis. J Am Soc Nephrol 2006, 17:285-293.
43. Chadha V., Schaefer F.S., Warady B.A. Dialysis-associated peritonitis in children. Pediatr Nephrol 2010, 25:425-440.
44. Warady B.A., Alexander S.R., Schaefer F., IPPR, et al. Peritonitis in children who receive long-term peritoneal dialysis: a prospective evaluation of therapeutic guidelines. J Am Soc Nephrol 2007, 18:2172-2179.
45. Warady B., Schaefer F., Holloway M., International Society for Peritoneal Dialysis (ISPD) Advisory Committee on Peritonitis Management in Pediatric Patients, et al. Consensus guidelines for the treatment of peritonitis in pediatric patients receiving peritoneal dialysis. Perit Dial Int 2000, 20:610-624.
46. Schaefer F., Feneberg R., Aksu N., et al. Worldwide variation of dialysis-associated peritonitis in children. Kidney Int 2007, 72:1374-1379.
47. Chua A.N., Goldstein S.L., Bell D., Brewer E.D. Topical mupirocin/sodium hypochlorite reduces peritonitis and exit-site infection rates in children. Clin J Am Soc Nephrol 2009, 4:1939-1943.
48. Bernardini J., Bender F., Florio T., et al. Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients. J Am Soc Nephrol 2005, 16:539-545.
49. Hui-Stickle S., Brewer E.D., Goldstein S.L. Pediatric ARF epidemiology at a tertiary care center from 1999 to 2001. Am J Kidney Dis 2005, 45:96-101.
50. Warady B.A., Bunchman T. Dialysis therapy for children with acute renal failure: survey results. Pediatr Nephrol 2000, 15:11-13.
51. Bunchman T.E., McBryde K.D., Mottes Te, et al. Pediatric acute renal failure: outcome by modality and disease. Pediatr Nephrol 2001, 16:1067-1071.
52. Symons J.M., Chua A.N., Somers M.J., et al. Demographic characteristics of pediatric continuous renal replacement therapy: a report of the prospective pediatric continuous renal replacement therapy registry. Clin J Am Soc Nephrol 2007, 2:732-738.
53. Hackbarth R., Bunchman T.E., Chua A.N., et al. The effect of vascular access location and size on circuit survival in pediatric continuous renal replacement therapy: a report from the PPCRRT registry. Int J Artif Organs 2007, 30:1116-1121.
54. Goldstein S.L. Continuous renal replacement therapy: mechanism of clearance, fluid removal, indications and outcomes. Curr Opin Pediatr 2011, 23:181-185.
55. McBryde K.D., Kershaw D.B., Bunchman T.E., et al. Renal replacement therapy in the treatment of confirmed or suspected inborn errors of metabolism. J Pediatr 2006, 148:770-778.
56. Arbeiter A.K., Kranz B., Wingen A.M., Bonzel K.E., et al. Continuous venovenous haemodialysis (CVVHD) and continuous peritoneal dialysis (CPD) in the acute management of 21 children with inborn errors of metabolism. Nephrol Dial Transplant 2010, 25:1257-1265.
57. Brophy P.D., Somers M.J.G., Baum M.A., et al. Multi-center evaluation of anticoagulation in patients receiving continuous replacement therapy (CRRT). Nephrol Dial Transplant 2005, 20:1416-1421.
58. Sutherland S.M., Zappitelli M., Alexander S.R., et al. Fluid overload and mortality in children receiving continuous renal replacement therapy: the prospective pediatric continuous renal replacement therapy registry. Am J Kidney Dis 2010, 55:316-325.
59. Zappitelli M., Michael M.D., Goldstein S.L., et al. Protein and calorie prescription for children and young adults receiving continuous renal replacement therapy: a report from the Prospective Pediatric Continuous Renal Replacement Therapy Registry Group. Crit Care Med 2008, 36:3239-3245.
60. Zappitelli M., Juarez M., Castillo L., Coss-Bu J., Goldstein S.L. Continuous renal replacement therapy amino acid, trace metal and folate clearance in critically ill children. Intensive Care Med 2009, 35:698-706.
61. Kuang D., Verbine A., Ronco C. Pharmacokinetics and antimicrobial dosing adjustment in critically ill patients during continuous renal replacement therapy. Clin Nephrol 2007, 67:267-284.